FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
|
6/25/2021 4:14:02 PM
|
Chg.
+0.540
|
Volume |
Bid4:15:10 PM |
Ask4:15:10 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
44.330EUR
|
+1.23%
|
25,916
Turnover: 1.14 mill. |
44.350Bid Size: 280 |
44.355Ask Size: 330 |
24.61 bill.EUR |
1.99% |
14.43 |
Business description
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Management board & Supervisory board
| CEO |
| Stephan Sturm |
| Management board |
| Rachel Empey, Dr. Ernst Wastler, Dr. Francesco De Meo, Michael Sen, Rice Powell, Sebastian Biedenkopf |
| Supervisory board |
| Wolfgang Kirsch, Grit Genster, Michael Diekmann, Bernd Behlert, Dr. Gerd Krick, Frauke Lehmann, Hauke Stars, Konrad Kölbl, Michael Sen, Oscar Romero De Paco, Prof. Dr. D. Michael Albrecht, Prof. Dr. Iris Löw-Friedrich, Stefanie Balling |
Company data
| Name: |
Fresenius SE & Co. KGaA |
| Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Phone: |
+49-6172-608-0 |
| Fax: |
- |
| E-mail: |
pr-fre@fresenius.com
|
| Internet: |
www.fresenius.de |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
56.49% |
| IPO date: |
12/18/1986 |
Investor relations
| Name: |
Markus Georgi |
| IR phone: |
+49-6172-608-2485 |
| IR Fax: |
+49-6172-608-2488 |
| IR e-mail: |
ir-fre@fresenius.com
|
Company calendar
|
CW 31 | 7/30/2021
Interim Report 2nd Quarter/6 Months
|
|
CW 45 | 11/2/2021
Interim Report 3rd Quarter/9 Months
|
Main Shareholders
| Freefloat |
|
56.49% |
| Else Kröner-Fresenius-Stiftung |
|
27.00% |
| BlackRock, Inc. |
|
4.74% |
| Allianz Global Investors GmbH |
|
2.98% |
| DWS Investment GmbH |
|
2.98% |
| The Capital Group Companies, Inc. |
|
2.92% |
| Henderson Group plc |
|
2.89% |